How to Use PNC27
Complete guide to PNC27 dosing, administration, timing, and protocol recommendations.
Quick Overview
A chimeric anti-cancer peptide containing p53 residues 12-26 linked to a membrane-penetrating sequence. Selectively kills cancer cells by binding to HDM-2 expressed on cancer cell membranes, inducing membrane pore formation and necrosis while leaving normal cells unaffected.
Dosing Guidelines
Common Dose
No human dose - research compound only
Frequency
Not applicable - no human use
Dose Range
Lab research: 0.1-0.3 mg/mL in cell culture
Note: Experimental anti-cancer peptide with strong lab evidence but NO human clinical trials. Research shows 0.2-0.3 mg/mL kills 90-100% of cancer cells in vitro while sparing normal cells. Only tested in cell cultures and ex vivo tissue samples. Not available through peptide vendors - strictly a research compound for cancer biology studies.
Administration Method
IV injection in animal studies - not for human use
Best Time to Take
Per research protocol
Experimental compound with short half-life. In vitro studies show optimal activity at 37°C with peptide re-addition every 24 hours.
Protocol Duration
Research protocols only - no human use data
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Limited safety data - research compound only
- •Highly selective for cancer cells in vitro
- •No cytotoxicity observed in normal cells (fibroblasts, leukocytes)
- •Temperature-dependent activity (37°C optimal, minimal at 17°C)
- •Not tested in human clinical trials
Frequently Asked Questions
What is the recommended dose for PNC27?
No human dose - research compound only
How do you administer PNC27?
IV injection in animal studies - not for human use
When is the best time to take PNC27?
Per research protocol
How long should you use PNC27?
Research protocols only - no human use data
This information is for educational purposes only. Always consult with a healthcare professional before using any peptide. Dosing information is based on research literature and community reports, not medical advice.